- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Valiant Laboratories IPO
₹170.25
+21.61% on listing
Listing-day close · NSE · 6 Oct 2023 · issue price ₹140
Valiant Laboratories’ ₹152 crore IPO was priced at ₹140 a share. It listed on the NSE on 6 Oct 2023 and closed its first day at ₹170.25, up 21.61% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹152 Cr
- Fresh issue
- ₹152 Cr
- Offer for sale
- —
- Lot size
- 105 shares
- Minimum investment
- ₹14,700
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 20.95× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹608 Cr
- ROE
- 33.73%
- ROCE
- 22.76%
- Debt to equity
- 0.59
- PAT margin
- 8.56%
- Promoter holding
- 100.00% → 74.94%
From the offer documents.
Listing
- Listing date
- 6 Oct 2023
- Issue price
- ₹140
- Open
- ₹162.15
- High
- ₹170.25
- Low
- ₹162.10
- Close
- ₹170.25
Listing day on the NSE. The close was +21.61% on the issue price.
VALIANTLAB share price todayFAQs
When did the Valiant Laboratories IPO open and close?
It opened on 27 Sep 2023 and closed on 3 Oct 2023.
What was the Valiant Laboratories IPO price?
The price band was ₹133–140 a share. The final issue price was ₹140.
What is the lot size and minimum investment?
One lot is 105 shares, ₹14,700 at ₹140 a share. Retail investors apply in whole lots.
How much did Valiant Laboratories raise?
₹152 crore: ₹152 crore of new shares.
How many times was the Valiant Laboratories IPO subscribed?
20.95 times overall.
How did Valiant Laboratories list?
It listed on the NSE on 6 Oct 2023 at ₹162.15 and closed the day at ₹170.25, up 21.61% on the ₹140 issue price.
Who is the registrar of the Valiant Laboratories IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app